Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine mon ...
NEW YORK, November 13, 2025 – Immunic, Inc. ( Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today ...
LITTLE ROCK, Ark., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Dillard’s, Inc. (NYSE: DDS) (the “Company” or “Dillard’s”) announced operating results for the 13 and 39 weeks ended November 1, 2025. This release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback